Back to Search
Start Over
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
- Source :
- British Journal of Haematology, 184(4), 643-646. Wiley, British Journal of Haematology, 184(4), 643-646. Wiley-Blackwell Publishing Ltd
- Publication Year :
- 2019
- Subjects :
- Oncology
medicine.medical_specialty
Myeloid
anti-thymocyte globulins
chronic graft-versus-host disease
PHASE-3
03 medical and health sciences
0302 clinical medicine
AML
Internal medicine
UNRELATED DONORS
medicine
acute myeloid leukaemia
business.industry
Retrospective cohort study
Hematology
GVHD-free relapse-free survival
medicine.disease
OPEN-LABEL
PREVENTION
Anti-thymocyte globulin
Transplantation
Leukemia
medicine.anatomical_structure
Graft-versus-host disease
030220 oncology & carcinogenesis
Transplantation Conditioning
Stem cell
business
reduced-intensity conditioning
030215 immunology
Subjects
Details
- ISSN :
- 00071048
- Volume :
- 184
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- British Journal of Haematology
- Accession number :
- edsair.doi.dedup.....6b5c504d2b8ba484d1dde94093bb726b